Role of tiotropium in the treatment of COPD

References

• AaronSDVandemheenKFergusson FitzgeraldM2007Tiotropium in Combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized TrialAnn Intern Med2007219[Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/European Respiratory Society Task Force2004[updated 2005 September 8]. Standards for the Diagnosis and Management of Patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society; Available from: http://www-test.thoracic.org/copd/
   Google Scholar
• [ATS/ERS] American Thoracic Society/European Respiratory Society Task Force2005Standardisation of Lung Function TestingEur Respir J2631933816055882
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEEnrightPL2002aHospitalizations and mortality in the Lung Health StudyAm J Respir Crit Care Med166333912153966
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJP1994Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health StudyJAMA272149715057966841
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEMurrayRP2002bSmoking and lung function of Lung Health Study participants after 11 yearsAm J Respir Crit Care Med166675912204864
   PubMed Web of Science ®Google Scholar
• AnthonisenNRWrightECHodgkinJEthe IPPB Trial Group1986Prognosis in chronic obstructive pulmonary diseaseAm Rev Respir Dis13314203510578
   PubMed Web of Science ®Google Scholar
• AnzuetoATashkinDMenjogeS2005One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropiumPulm Pharmacol & Ther18758115649848
   PubMed Web of Science ®Google Scholar
• BarnesPJ2000The pharmacological properties of tiotropiumChest11763s6s10673478
   PubMed Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCA2006aInhaled tiotropium for stable chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews2CD002876
   Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCA2006bTiotropium for stable chronic obstructive pulmonary disease: a meta-analysisThorax618546216844726
   PubMed Web of Science ®Google Scholar
• BeehKMBeierJBuhlR2006Efficacy of tiotropium bromide (Spiriva®) in patients with chronic-obstructive pulmonary disease (COPD) of different severitiesPneumologie60341616761228
   PubMedGoogle Scholar
• BelmanMJBotnickWCShinJW1996Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med153967758630581
   PubMed Web of Science ®Google Scholar
• BelmonteKE2005Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary diseaseProc Am Thorac Soc22973016267352
   PubMedGoogle Scholar
• Boehringer Ingelheim [online]Accessed 9 Nov 2006. URL: http://www.boehringer-ingelheim.ca/news_releases/2004/2004-03-09.asp
   Google Scholar
• BriggsDDJrCovelliHLapidusR2005Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPDPulm Pharmacol Ther1839740416179215
   PubMed Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesM2003Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax5839940412728159
   PubMed Web of Science ®Google Scholar
• CalverleyPM2006Dynamic hyperinflation: is it worth measuring?Proc Am Thorac Soc32394416636092
   PubMedGoogle Scholar
• CalverleyPMALeeATowseLJ2003Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax588556014514937
   PubMed Web of Science ®Google Scholar
• Canadian Thoracic Society2003Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary DiseaseCan Respir J104A65A
   Google Scholar
• CasaburiRBriggsDDJrDonohueJF2000The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: A 13-week multicenter trialChest118129430211083677
   PubMed Web of Science ®Google Scholar
• CasaburiRKukafkaDCooperCB2005Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest1278091715764761
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPW2002A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J192172411866001
   PubMed Web of Science ®Google Scholar
• CazzolaMCentanniSSantusP2004aThe functional impact of adding salmeterol and tiotropium in patients with stable COPDRespir Med9812142115588043
   PubMed Web of Science ®Google Scholar
• CazzolaMDi MarcoFSantusP2004bThe pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPDPulm Pharmacol Ther1735914643169
   PubMed Web of Science ®Google Scholar
• CelliBZuWallackRWangS2003Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumesChest12417434814605043
   PubMed Web of Science ®Google Scholar
• ChodoshSFlandersJSerbyCW2001Effective use of Handihaler dry powder inhalation system over a range of COPD severityJ Aerosol Med143091511693842
   PubMedGoogle Scholar
• CovelliHBhattacharyaSCassinoC2005Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary diseasePharmacotherapy2517081816305289
   PubMed Web of Science ®Google Scholar
• DonohueJF2005Minimal clinically important differences in COPD lung functionJ COPD211124
   PubMedGoogle Scholar
• D’SouzaAOSmithMJMillerLAAn appraisal of pharmacoeconomic evidence of maintenance therapy for COPDChest129169370816778291
   PubMed Web of Science ®Google Scholar
• DusserDBravoM-LIaconoPon behalf the MISTRAL study group2006The effect of tiotropium on exacerbations and airflow in patients with COPDEur Respir J275475516507855
   PubMed Web of Science ®Google Scholar
• FriedmanMMenjogeSSAntonSF2004Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD)Pharmacoeconomics22741915250751
   PubMed Web of Science ®Google Scholar
• HalbertRJIsonakaSGeorgeD2003Interpreting COPD prevalence estimates: what is the true burden of disease?Chest12316849212740290
   PubMed Web of Science ®Google Scholar
• HighlandKBStrangeCHeffnerJE2003Long term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysisAnn Intern Med1389697312809453
   PubMed Web of Science ®Google Scholar
• HillemanDEDewanNMaleskerM2000Pharmacoeconomic evaluation of COPDChest11812788511083675
   PubMed Web of Science ®Google Scholar
• JonesPWBoshTK1997Quality of life changes in COPD patients treated with salmeterolAm J Respir Crit Care Med155128399105068
   PubMed Web of Science ®Google Scholar
• KestenSJaraMWentworthC2006Pooled clinical trial analysis of tiotropium safetyChest1301695117166984
   PubMed Web of Science ®Google Scholar
• KoyamaSRennardSIRobbinsRA1992Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activityAm J Physiol262L466711566862
   PubMed Web of Science ®Google Scholar
• LittnerMRIlowiteJSTashkinDP2000Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16111364210764302
   PubMed Web of Science ®Google Scholar
• Lopez-VidrieroMTCostelloJClarkTJ1975Effect of atropine on sputum productionThorax3054371198394
   PubMed Web of Science ®Google Scholar
• MahlerDAWeinbergDHWellsCK1984The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexesChest8575186723384
   PubMed Web of Science ®Google Scholar
• MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest12811687816162703
   PubMed Web of Science ®Google Scholar
• McNicholasWTCalverleyPMLeeA2004Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPDEur Respir J238253115218993
   PubMed Web of Science ®Google Scholar
• MichaudCMChristopherJLMurrayCJL2001Burden of disease - implications for future researchJAMA285535911176854
   PubMed Web of Science ®Google Scholar
• National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care2004Thorax593913014694246
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Global Initiative for Chronic Obstructive Lung Disease. Updated 2005. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Accessed 3 Nov 2006. URL: http://www.goldcopd.org
   Google Scholar
• NiewoehnerDECollinsDErblandMLfor the Department of Veterans Affairs Cooperative Study Group2000Relation of FEV1 to clinical outcomes during exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1611201510764312
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteC2005Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med1433172616144890
   PubMed Web of Science ®Google Scholar
• NomuraJHosoiTOkumaY2003The presence and functions of muscarinic receptors in human T-cells: the involvement in IL-2 and IL-2 receptor systemLife Sci722121612628467
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlugeTGerkenF2004Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J238324015218994
   PubMed Web of Science ®Google Scholar
• O’DonnellDELamMWebbKA1998Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1581557659817708
   PubMed Web of Science ®Google Scholar
• OksuzHTamerCAkogluS2006Acute angle-closure glaucoma precipitated by local tiotropium absorptionPulm Pharmacol Ther[Epub ahead of print] doi:10.1016/j.pupt.2006.07.002.
   Web of Science ®Google Scholar
• OostenbrinkJBRutten-van MolkenMPVanMJ2004One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary diseaseEur Respir J23241914979498
   PubMed Web of Science ®Google Scholar
• PraetoriusGM2005[Postoperative intestinal paralysis caused by the muscarinic receptor blocker tiotropium bromide]. [German]Urologe44393515672237
   PubMed Web of Science ®Google Scholar
• RedelmeierDAGoldsteinRSMinST1996Spirometry and dyspnea in patients with COPDChest109116388625661
   PubMed Web of Science ®Google Scholar
• RiesAL2006Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspneaAm J Med119S1220
   PubMed Web of Science ®Google Scholar
• RodrigoGJNanniniLJ2006Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis [online]Pulm Pharmacol Therdoi:10.1016/j.pupt.2006.02.003.
   Web of Science ®Google Scholar
• SalpeterSRBuckleyNSSalpeterEE2006Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPDJ Gen Intern Med2110111916970553
   PubMed Web of Science ®Google Scholar
• SinDDMcAlisterFAManSF2003Contemporary management of chronic obstructive pulmonary disease: scientific reviewJAMA29023011214600189
   PubMed Web of Science ®Google Scholar
• SullivanSDRamseySDLeeTA2000The economic burden of COPDChest1175910631188
   PubMed Web of Science ®Google Scholar
• SutherlandERAllmersHAyasNT2003Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysisThorax589374114586043
   PubMed Web of Science ®Google Scholar
• TamaokiJChiyotaniATagayaE1994Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitisThorax495458016790
   PubMed Web of Science ®Google Scholar
• TashkinDP2006The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understandingAm J Med11910 Suppl 1637216996901
   PubMed Web of Science ®Google Scholar
• TashkinDKestenS2003Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responsesChest1231441912740259
   PubMed Web of Science ®Google Scholar
• TurckDWeberWSigmundR2004Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairmentJ Clin Pharmacol441637214747425
   PubMed Web of Science ®Google Scholar
• TurinoGM2005Therapeutic gains of prolonged bronchial dilatation in chronic obstructive pulmonary diseaseAnn Intern Med143386716144897
   PubMed Web of Science ®Google Scholar
• van NoordJAAumannJLJanssensE2005Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEur Respir J262142216055868
   PubMed Web of Science ®Google Scholar
• van NoordJAAumannJLJanssensE2006Effects of tiotropium with and without formoterol on airflow obstruction and resting hyper-inflation in patients with COPDChest1295091716537846
   PubMed Web of Science ®Google Scholar
• van NoordJASmeetsJJCustersFLKorducki2002Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary diseaseEur Respir J196394411998992
   PubMed Web of Science ®Google Scholar
• VerkindreCBartFAguilaniuB2006The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary diseaseRespiration73420716484769
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAPM2002Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J192091611871363
   PubMed Web of Science ®Google Scholar
• WiltTJNiewoehnerDKimC-B2005Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evidence Report/Technology Assessment No. 121 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290–02–0009.) AHRQ Publication No. 05-E017–2. Rockville, MD. Agency for Healthcare Research and Quality. September 2005.
   Google Scholar
• WitekTJJrMahlerDA2003Meaningful effect size and patterns of response of the transition dyspnea indexJ Clin Epidemiol62485512725879
   PubMed Web of Science ®Google Scholar
• World Health Organization2000World health report [online]. Geneva: World Health Organization. URL: URL: http://www.who.int/whr/2000/en/statistics.htm
   Google Scholar